packageUmbralisib

umbralisib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Umbralisib is a protein kinase inhibitor that was used to treat certain blood cancers, including lymphoma. It is no longer used: its approval was withdrawn after safety concerns, including an increased risk of death seen in clinical trials.

Summary written by glm-5.3-flash from Wikidata Q27088612 and the WHO ATC classification; not checked by a person.

name:umbralisib
ATC codes:L01EX25
DrugBank:DB14989
PubChem CID:72950888
Wikidata:Q27088612
formula:C31H24F3N5O3
molar mass:571.559 g/mol (PubChem CID 72950888)
logP:5.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown